AnaCardio
PrivateLast Round
Series A
Extension
Jan 9, 2025
Est. Valuation
$1.71M
Total Funding Raised
$34.24M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
AnaCardio is a clinical-stage biopharmaceutical company that develops novel drugs to treat heart failure.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AnaCardio Comparables
Compare AnaCardio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Zensun (Shanghai) Sci & Tech Co., Ltd. | 78% | |
| Cardurion Pharmaceuticals | 77% | |
| Seismic Pharmaceutical Holdings | 75% | |
AnaCardio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Jan 9, 2025 | ||||
| Series A | Sep 8, 2022 | ||||
| VC Round | Feb 3, 2022 | ||||
| Seed | Jun 17, 2021 |
Key People
Founding team and executive leadership
AnaCardio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| 3B FUTURE Health Fund | Series A |
| Industrifonden | Series A Extension, VC Round, Series A |
| Novo Holdings | Series A Extension |
| Karolinska Development AB | Series A, VC Round, Seed |
| Pureos Bioventures | Series A Extension |
| Flerie AB | Series A Extension, Series A |
| Sound Bioventures | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 15, 2026
Monthly visitors increased 31% MoM.
- Mar 26, 2026
AC01 study selected for Late-Breaking Science at Heart Failure 2026 Congress.
AnaCardio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about AnaCardio's valuation, stock price, and market status.